Tenaya Therapeutics, Inc. Number of Operating Segments
Tenaya Therapeutics, Inc. (TNYA) reported Number of Operating Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-05
- Tenaya Therapeutics, Inc. number of operating segments for the quarter ending 2026-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Tenaya Therapeutics, Inc. number of operating segments for the quarter ending 2025-03-31 was 1.00 Segment.
- Tenaya Therapeutics, Inc. number of operating segments for fiscal 2025 was 1.00 Segment, a 0.00% change from fiscal 2024.
- Tenaya Therapeutics, Inc. number of operating segments for fiscal 2024 was 1.00 Segment.
- Tenaya Therapeutics, Inc. number of operating segments for fiscal 2022 was 1.00 Segment, a 0.00% change from fiscal 2021.
- Tenaya Therapeutics, Inc. number of operating segments for fiscal 2021 was 1.00 Segment.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-11 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-03-10 | |||
| 2022-12-31 | 1.00 Segment 10-K · filed 2023-03-08 | |||
| 2021-12-31 | 1.00 Segment 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |